Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 4, 2003
[Evidence-based management of chemotherapy related thrombocytopenia]
Hiroshi Ishiguro, Man C Fung, Yoshio Inoue, et al.
Molecular Cancer Therapeutics
|
July 16, 2005
Cyclin A-associated kinase activity is needed for paclitaxel sensitivity
Takeshi Takahashi, Fumiyuki Yamasaki, Tamotsu Sudo, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
January 19, 2011
Synergistic effect of combined HMG-CoA reductase inhibitor and angiotensin-II receptor blocker therapy in patients with chronic heart failure: the HF-COSTAR trial
Yasuhiro Maejima, Kiyoshi Nobori, Yuichi Ono, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association
|
May 17, 2020
Predictors of fatal outcome after severe necrotizing fasciitis: Retrospective analysis in a tertiary hospital for 20 years
Susumu Adachi, Tsuneari Takahashi, Kensuke Minami, et al.
Anticancer Research
|
May 16, 2009
A phase I/II study of docetaxel and gemcitabine combination for chemotherapy-resistant ovarian cancer
Yoshio Itani, Kenichi Hosokawa, Kimihiko Ito, et al.
Biochemical and Biophysical Research Communications
|
August 7, 2002
Expression of cyclin D1 and CDK4 causes hypertrophic growth of cardiomyocytes in culture: a possible implication for cardiac hypertrophy
Mimi Tamamori-Adachi, Hiroshi Ito, Kiyoshi Nobori, et al.
Journal of Molecular and Cellular Cardiology
|
October 24, 2002
ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3
Kiyoshi Nobori, Hiroshi Ito, Mimi Tamamori-Adachi, et al.
Life Sciences
|
May 23, 2006
HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1
Kino Morikawa-Futamatsu, Susumu Adachi, Yasuhiro Maejima, et al.
Analytical Chemistry
|
December 11, 2019
Evaluation of Analytical Precision of Polychromatic Simultaneous WDXRF Spectrometer and Application to Valence Analysis of Cathode Materials of Lithium-Ion Batteries
Kenji Sato, Tetsuya Yoneda, Takuro Izumi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma
Jacek Jassem, Rodryg Ramlau, Armando Santoro, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 4, 2003
[Evidence-based management of chemotherapy related thrombocytopenia]
Hiroshi Ishiguro, Man C Fung, Yoshio Inoue, et al.
Molecular Cancer Therapeutics
|
July 16, 2005
Cyclin A-associated kinase activity is needed for paclitaxel sensitivity
Takeshi Takahashi, Fumiyuki Yamasaki, Tamotsu Sudo, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
January 19, 2011
Synergistic effect of combined HMG-CoA reductase inhibitor and angiotensin-II receptor blocker therapy in patients with chronic heart failure: the HF-COSTAR trial
Yasuhiro Maejima, Kiyoshi Nobori, Yuichi Ono, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association
|
May 17, 2020
Predictors of fatal outcome after severe necrotizing fasciitis: Retrospective analysis in a tertiary hospital for 20 years
Susumu Adachi, Tsuneari Takahashi, Kensuke Minami, et al.
Anticancer Research
|
May 16, 2009
A phase I/II study of docetaxel and gemcitabine combination for chemotherapy-resistant ovarian cancer
Yoshio Itani, Kenichi Hosokawa, Kimihiko Ito, et al.
Biochemical and Biophysical Research Communications
|
August 7, 2002
Expression of cyclin D1 and CDK4 causes hypertrophic growth of cardiomyocytes in culture: a possible implication for cardiac hypertrophy
Mimi Tamamori-Adachi, Hiroshi Ito, Kiyoshi Nobori, et al.
Journal of Molecular and Cellular Cardiology
|
October 24, 2002
ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3
Kiyoshi Nobori, Hiroshi Ito, Mimi Tamamori-Adachi, et al.
Life Sciences
|
May 23, 2006
HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1
Kino Morikawa-Futamatsu, Susumu Adachi, Yasuhiro Maejima, et al.
Analytical Chemistry
|
December 11, 2019
Evaluation of Analytical Precision of Polychromatic Simultaneous WDXRF Spectrometer and Application to Valence Analysis of Cathode Materials of Lithium-Ion Batteries
Kenji Sato, Tetsuya Yoneda, Takuro Izumi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma
Jacek Jassem, Rodryg Ramlau, Armando Santoro, et al.
Page
of 4